跳至主要内容
临床试验/NCT05517408
NCT05517408招募中不适用

Dose Exploration of Ciprofol for Sedation in Gastrointestinal Endoscopic Diagnosis and Treatment of Obese Patients.

RenJi Hospital1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2022年9月19日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
30
试验地点
1
主要终点
Calculating the the median effective dose (ED50) of ciprofol for sedation gastrointestinal endoscopy in obese patients.

研究概览

简要总结

Ciprofol is a new anesthetic, which combines with γ- Aminobutyric acid-a (GABAA) receptor. Ciprofol has shown equivalent anesthetic efficacy of propofol at 1/4 to 1/5 of the dosage. Ciprofol has the pharmacodynamic characteristics of rapid onset, stable and rapid recovery. Phase III clinical results showed that the incidence of injection pain and respiratory and circulatory depression of ciprofol was lower than that of propofol. Therefore, ciprofol has a good application prospect in sedation for gastrointestinal endoscopy, especially for obese patients. In the current study, we would explore the proper dose of Ciprofol in sedated gastrointestinal endoscopy in obese patients.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age, ≤18 and ≤60 years, no gender limit
  • Undergoing routine gastrointestinal endoscopic diagnosis and treatment
  • American Society of Anesthesiologists (ASA) classification I-II
  • Body Mass Index(BMI) ≥28kg/m^2
  • Clearly understand and voluntarily participate in the study; provide signed informed consent

排除标准

  • Unhealthy alcohol drinking, defined by more than three standard drinks per day (≈10 g alcohol , equivalent to 50 g of strong Chinese spirits)
  • Drug abuse history within 3 months before the screening period
  • People who are known to be allergic to eggs, bean products, opioids and other drugs, propofol, etc
  • The researcher believes that patients should not participate in this trial

研究组 & 干预措施

Ciprofol group

Experimental

干预措施: ciprofol (Drug)

结局指标

主要结局

Calculating the the median effective dose (ED50) of ciprofol for sedation gastrointestinal endoscopy in obese patients.

时间窗: Patients will be followed for the duration of hospital stay, an expected average of 2 hours

次要结局

  • Calculating the the ED95 of ciprofol for sedation gastrointestinal endoscopy in obese patients.(Patients will be followed for the duration of hospital stay, an expected average of 2 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验